down arrow

Zydus Lifesci.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE010B01027
  • NSEID: ZYDUSLIFE
  • BSEID: 532321
INR
869.00
24.4 (2.89%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 7.82 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Zydus Lifesciences Ltd stock-summary
stock-summary
Zydus Lifesciences Ltd
Large Cap
Pharmaceuticals & Drugs
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer well
Company Coordinates stock-summary
Company Details
Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W Ahmedabad Gujarat : 382481
stock-summary
Tel: 91-079-26868100
stock-summary
upen.shah@zyduscadila.com
Registrar Details
Sharepro Services (India) Pvt Ltd, 13A/B 2nd Floor, Samitha Warehousing Complex, Behind Sakinaka Telephone Exchange, Andheri Kurla Road, Sakinaka, Andheri (East), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 100.62 Cr
Number of Shares
100.62 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
18-Mar-2024
100.62
100.62
-5970149
1
Buy Back of Shares
22-Jul-2022
101.22
101.22
-11538461
0
Buy Back of Shares
22-Jul-2022
101.22
101.22
-11538461
1
Buy Back of Shares
06-Oct-2015
102.37
102.37
818994080
1
Stock Split
06-Oct-2015
102.37
102.37
818994080
1
Stock Split
05-Apr-2010
20.47
102.37
68249507
5
Bonus
05-Apr-2010
20.47
102.37
68249507
5
Bonus
07-Feb-2009
13.65
68.25
10885305
5
Merger
07-Feb-2009
13.65
68.25
10885305
5
Merger
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 31 Schemes (6.32%)

FIIs

Held by 624 FIIs (7.53%)

Promoter with highest holding

Zydus Family Trust (pankaj R. Patel, Pritiben P. Patel And Sharvil P. Patel-trustees) (74.96%)

Highest Public shareholder

Llife Insurance Corporation Of India (3.53%)

Individual Investors Holdings

5.47%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Pankaj R Patel
Chairman (Non-Executive)
16.0 lacs
Sharvil P Patel
Managing Director
26.25 cr
Mukesh M Patel
Director
48.0 lacs
Nitin Raojibhai Desai
Independent Director
43.0 lacs
Dharmishta N Rawal
Independent Director
45.0 lacs
Apurva S Diwanji
Independent Director
46.0 lacs
Ganesh N Nayak
Executive Director
12.0 cr
Bhadresh K Shah
Independent Director
46.0 lacs
Dhaval N Soni
Company Sec. & Compli. Officer
0
Akhil A. Monappa
Independent Director
12.0 lacs
Upasana Konidela.
Independent Director
12.0 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchases of Finished Goods
362.7
0%
 
100
Purchases of Finished Goods
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Products
6,207.00
95.60%
Other Operating Revenues - Export Incentives
169.30
2.61%
Other Operating Revenues - Miscellaneous Income
114.00
1.76%
 
95.6
Pharmaceutical Products
4.4
Pharmaceutical Products
2.61
Other Operating Revenues - Export Incentives
97.39
Other Operating Revenues - Export Incentives
1.76
Other Operating Revenues - Miscellaneous Income
98.24
Other Operating Revenues - Miscellaneous Income
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
5,269 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1,024 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 87,442 Cr (Large Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.36%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

19.63%

stock-summary
Price to Book

3.89